{
    "clinical_study": {
        "@rank": "119299", 
        "acronym": "IGRT", 
        "arm_group": [
            {
                "arm_group_label": "definitive radiation + concomitant chemo", 
                "arm_group_type": "Experimental", 
                "description": "These patients will have chemotherapy during the time of radiation treatment"
            }, 
            {
                "arm_group_label": "neoadjuvant chemo", 
                "arm_group_type": "Experimental", 
                "description": "These patients will have chemotherapy prior to other radiation treatment."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the utility of kilovoltage (kV) cone beam CT\n      imaging to track the dose delivered in head and neck cancer patients, to assess the benefit\n      of cone beam CT to patients set-up for radiation treatment, to determine how shifts based on\n      kV cone beam CT compare to the standard approach (orthogonal pair), and to develop remote\n      access tools (preferably internet-based) so that the MD can approve these plans in real\n      time."
        }, 
        "brief_title": "Adaptive Radiation Therapy for Head & Neck Cancer Patients", 
        "completion_date": {
            "#text": "February 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Cancer of Head and Neck", 
        "condition_browse": {
            "mesh_term": "Head and Neck Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "The investigators' secondary objectives for this study are to assess the possibility of\n      using kV cone beam for treatment replanning as compared to standard the treatment planning,\n      to determine the need and feasibility of adaptive radiation therapy, to develop concept of\n      establishing cumulative DVH (C-DVH) with daily updates  and compare it to planned DVH\n      (P-DVH), to identify tolerance margins, to evaluate local control, locoregional control,\n      distant metastasis, and overall survival, to assess patient quality of life,and to develop\n      predictors of patients which may benefit from ART."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients should have an ECOG (Eastern Clinical Oncology Group) performance status of\n             0-2\n\n          -  Patients should meet at least one of the following criteria:\n\n               1. Locally advanced cancer (T3-T4 and/or N2-N3)\n\n               2. Tumors wrapping around critical structures such as the optic nerves, optic\n                  chiasm, or brainstem\n\n               3. Significant expected weight loss.\n\n        Exclusion Criteria:\n\n          -  Previous surgical procedure more significant than a biopsy to the primary tumor or\n             regional lymph nodes.\n\n          -  Poor renal function (inability to undergo a CT with IV contrast)\n\n          -  Previous radiation therapy to the head and neck.\n\n          -  Inability to tolerate prolonged immobilization.\n\n          -  Children and women who are pregnant or decline to use contraception."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01853670", 
            "org_study_id": "167-08"
        }, 
        "intervention": [
            {
                "arm_group_label": "definitive radiation + concomitant chemo", 
                "intervention_name": "concurrent chemo + IGRT", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": "neoadjuvant chemo", 
                "intervention_name": "neoadjuvant chemo + IGRT", 
                "intervention_type": "Radiation"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 7, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10003"
                    }, 
                    "name": "Beth Israel Medical Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Kenneth Hu, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Louis Harrison, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10003"
                    }, 
                    "name": "Beth Israel Medical Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Ken Hu, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Louis Harrison, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Kilovoltage Conebeam Imaging Based Adaptive Radiation Therapy for Head & Neck Patients Treated With Intensity Modulated Radiation Therapy", 
        "overall_contact": {
            "email": "Khu@chpnet.org", 
            "last_name": "Kenneth Hu, MD", 
            "phone": "2128448087"
        }, 
        "overall_official": {
            "affiliation": "Beth Israel Medical Center", 
            "last_name": "Ken Hu, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "This will assessed by CT scan or MRI 4-5 weeks post concurrent chemo.", 
            "measure": "Clinical patient response", 
            "safety_issue": "No", 
            "time_frame": "From the date of initiation of radiation therapy, until date of first progression or until date of death (approximately 5 years)."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01853670"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "This will be assessed using the: Fact Head & Neck form at baseline, and weekly throughout radiation treatment.", 
            "measure": "Patient quality of life", 
            "safety_issue": "No", 
            "time_frame": "During radiation therapy (7-9 weeks)"
        }, 
        "source": "Beth Israel Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beth Israel Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2009", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}